Test to Stay in School: COVID-19 Testing Following Exposure in School Communities
NCT05052580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4733
Last updated 2023-11-27
Summary
Participants in school communities who have been exposed to SARS-CoV-2 will be tested for COVID-19 on the day of exposure (day 1) and at days 3, 5, and 7 following initial known exposure. Mitigation practices including masking, the context of exposure (classroom, school bus, after school sporting event, lunch, etc.), and results of COVID-19 test will be documented.
Conditions
- Covid19
Interventions
- OTHER
-
COVID-19 Testing
Participants who consent to participate in this study will be tested at days 1, 3, 5, and 7 following a known COVID-19 exposure on day 0. If the COVID-19 tests are negative, the participant will remain in the school environment. A positive COVID-19 test or the development of symptoms on any day after exposure would require isolation according to school, local and state guidelines.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Kanecia Zimmerman, MD, MPH · Duke University
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-01
- Primary Completion
- 2022-03-28
- Completion
- 2022-03-28
Countries
- United States
Study Locations
More Related Trials
-
Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008
NCT06585683 ·Status: COMPLETED
-
Vitamin D Supplementation in TB Prevention
NCT02276755 ·Status: COMPLETED ·Phase: PHASE3
-
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
NCT05007795 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection
NCT02687529 ·Status: COMPLETED
-
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
NCT06022146 ·Status: RECRUITING ·Phase: PHASE3
-
The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa
NCT01990274 ·Status: COMPLETED ·Phase: NA
-
PCR Techniques of Dried Sputum Using a Spotcard
NCT04055584 ·Status: UNKNOWN
-
A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis
NCT00317330 ·Status: COMPLETED ·Phase: PHASE3
-
Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial
NCT05017324 ·Status: UNKNOWN ·Phase: NA
-
Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers
NCT00311220 ·Status: UNKNOWN ·Phase: PHASE4
-
Trial of High-Dose Rifampin in Patients With TB
NCT01408914 ·Status: COMPLETED ·Phase: PHASE2
-
Food Incentives for TB Treatment Compliance in East Timor (FITTCET)
NCT00192556 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability And Pharmacokinetics Study Of Single Doses Of PNU-100480 In Healthy Adults
NCT00871949 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB
NCT03350048 ·Status: COMPLETED
-
Start TB Patients on ART and Retain on Treatment (START Study)
NCT01872390 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults
NCT05824091 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administration
NCT00793702 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2556286 in Healthy Adult Participants
NCT04472897 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of the QuantiFERON-TB Test.
NCT02256839 ·Status: COMPLETED
-
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
NCT06580639 ·Status: RECRUITING
-
Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB
NCT04752592 ·Status: COMPLETED ·Phase: NA
-
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
NCT01622140 ·Status: COMPLETED
-
Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB
NCT01392911 ·Status: COMPLETED ·Phase: PHASE2
-
Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection
NCT00000955 ·Status: COMPLETED ·Phase: NA
-
Integrated Discovery and Development of Innovative TB Diagnostics
NCT06624501 ·Status: COMPLETED